Home / SME Stocks / Invicta Diagnostic
Invicta Diagnostic: IPO, Share Price and Results Since Listing
Invicta Diagnostic listed on NSE Emerge on 8 December 2025 after an IPO at INR 85 a share. On 11 November 2026 the shares closed at INR 74.50, 12.35% below the issue price. For H2 FY2026 it reported revenue of INR 15.41 crore and a profit after tax of INR 0.79 crore.
Key Facts
- IPO dates
- 1 December 2025 to 3 December 2025
- Issue price
- INR 85
- Issue size
- INR 28.12 crore
- Subscription
- 4.34 times
- Lead manager
- Socradamus Capital Private Limited
- Listing day
- opened at INR 100 (+17.65%), closed at INR 96.70 (+13.76%)
- Listed on NSE Emerge
- 8 December 2025
- Symbol
- INVICTA
- Latest close
- INR 74.50 on 11 November 2026
- Against issue price
- -12.35%
- Lot size now
- 1,600 shares (INR 1,19,200 at the latest close)
Results Filed With NSE
Consolidated figures, INR crore. Change compares with the same period a year earlier.
| Period | Revenue | Change | Profit after tax | EPS (INR) | Filed | |
|---|---|---|---|---|---|---|
| H2 FY2026 | 15.41 | – | 0.79 | 0.79 | after listing | 18 May 2026 |
| FY2026 | 32.35 | – | 4.87 | 4.90 | after listing | 18 May 2026 |
Promoter Holding
Promoter holding has moved from 66.70% on 7 December 2025 to 66.70% on 30 September 2026 (0 percentage points).
| As of | Promoters | Public |
|---|---|---|
| 30 September 2026 | 66.70% | 33.30% |
| 31 March 2026 | 66.70% | 33.30% |
| 7 December 2025 | 66.70% | 33.30% |
Anchor Lock-ins
| Lock-in | Ends |
|---|---|
| 30 days | 3 January 2026 |
| 90 days | 4 March 2026 |
Next Board Meeting
14 November 2026: Financial results
Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.